Patient factors associated with hemoglobin A1C change with pioglitazone as adjunctive therapy in type 2 Diabetes Mellitus

OBJECTIVE: To identify patient factors associated with change in hemoglobin A1C (A1C) with adjunct pioglitazone therapy in routine clinical practice. METHODS: This was a retrospective analysis of adult type 2 diabetes mellitus patients in a health maintenance organization setting who were newly-init...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Mongthuong T., Delate, Thomas, Bachmann, Shakti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141869/
https://www.ncbi.nlm.nih.gov/pubmed/25157285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141869/
https://www.ncbi.nlm.nih.gov/pubmed/25157285

Ejemplares similares